Navigation Links
Vascular Dementias Global Clinical Trials Review, H2, 2014
Date:8/25/2014

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is availabl e in its catalogue:

Vascular Dementias Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02312352/Vascular-Dementias-Global-Clinical-Trials-Review-H2-2014.html

Vascular Dementias Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Vascular Dementias Global Clinical Trials Review, H2, 2014" provides data on the Vascular Dementias clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vascular Dementias. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vascular Dementias. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vascular Dementias 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Vascular Dementias to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Vascular Dementias to Central Nervous System Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18

Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Vascular Dementias 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Vascular Dementias Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Pfizer Inc. 30
Clinical Trial Overview of Pfizer Inc. 30
Johnson & Johnson 31
Clinical Trial Overview of Johnson & Johnson 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Janssen-Cilag A.G. 33
Clinical Trial Overview of Janssen-Cilag A.G. 33
Golgi Pharmaceuticals Ltd 34
Clinical Trial Overview of Golgi Pharmaceuticals Ltd 34
EVER Neuro Pharma GmbH 35
Clinical Trial Overview of EVER Neuro Pharma GmbH 35
Eisai Co., Ltd. 36
Clinical Trial Overview of Eisai Co., Ltd. 36

Dr. Willmar Schwabe Pharmaceuticals 37
Clinical Trial Overview of Dr. Willmar Schwabe Pharmaceuticals 37
Diaxonhit S.A. 38
Clinical Trial Overview of Diaxonhit S.A. 38
Clinical Trial Overview of Top Institutes / Government 39
University of Pennsylvania 39
Clinical Trial Overview of University of Pennsylvania 39
Ministry of Education, Culture, Sports, Science and Technology 40
Clinical Trial Overview of Ministry of Education, Culture, Sports, Science and Technology 40
Radboud University 41
Clinical Trial Overview of Radboud University 41
University of Pittsburgh 42
Clinical Trial Overview of University of Pittsburgh 42
Cardiff University 43
Clinical Trial Overview of Cardiff University 43
University of Western Sydney 44
Clinical Trial Overview of University of Western Sydney 44
Chang Gung Memorial Foundation 45
Clinical Trial Overview of Chang Gung Memorial Foundation 45
VU University Medical Center 46
Clinical Trial Overview of VU University Medical Center 46
Samsung Medical Center 47
Clinical Trial Overview of Samsung Medical Center 47
The Sheba Medical Center 48
Clinical Trial Overview of The Sheba Medical Center 48
Five Key Clinical Profiles 49
Appendix 67

Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables
Vascular Dementias Therapeutics, Global, Clinical Trials by Region, 2014* 7
Vascular Dementias Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Vascular Dementias Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Vascular Dementias Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Vascular Dementias Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Vascular Dementias Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19

Vascular Dementias Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Vascular Dementias Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Vascular Dementias Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Vascular Dementias Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Vascular Dementias Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Vascular Dementias Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Vascular Dementias Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Vascular Dementias Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Vascular Dementias Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 30
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 31
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 32
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen-Cilag A.G., 2014* 33
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Golgi Pharmaceuticals Ltd, 2014* 34

Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by EVER Neuro Pharma GmbH, 2014* 35
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 36
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe Pharmaceuticals, 2014* 37
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Diaxonhit S.A., 2014* 38
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 39
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Education, Culture, Sports, Science and Technology, 2014* 40
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014* 41
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 42
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2014* 43
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Western Sydney, 2014* 44
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 45
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014* 46
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 47
Vascular Dementias Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014* 48

List of Figures
Vascular Dementias Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Vascular Dementias Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Vascular Dementias Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Vascular Dementias Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Vascular Dementias Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Vascular Dementias Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Vascular Dementias to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Vascular Dementias Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Vascular Dementias Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Vascular Dementias Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Vascular Dementias Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Vascular Dementias Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Vascular Dementias Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Vascular Dementias Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Vascular Dementias Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Vascular Dementias Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Vascular Dementias Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68

To order this report: Vascular Dementias Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02312352/Vascular-Dementias-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Christie FreshStart Program Helps Hospital Replace Current Vascular Imaging Devices With Hospital-Wide VeinViewer Solution
2. Global Cardiovascular Monitoring and Diagnostic Devices (ECG Systems, Stress ECG, Resting ECG) Market - Forecast to 2019
3. The Canadian Peripheral Vascular Device Market Will Only Expand Slightly As Procedure Growth is Largely Offset by Declining Prices
4. Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018
5. Asia-Pacific Cardiovascular Prosthetic Devices Market Outlook to 2020
6. United Kingdom Cardiovascular Procedures Outlook to 2020
7. Russia Cardiovascular Procedures Outlook to 2020
8. Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device
9. Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led By Targeted Technology Funds
10. Stone & Magnanini LLP Announces $520,000 Department of Justice False Claims Act Settlement With Vascular Solutions, Inc.
11. New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/13/2017)... 2017 Constant research ongoing in the ... contribute to the demand for western blotting technique. The global  ... US$ 551.0 Mn by 2016 end. Developing economies in ... markets for western blotting, whereas North America ... ...
(Date:1/13/2017)... 13, 2017  Alfalfa, cattle, leafy greens and rosy cheeked ... film , which emphasizes the food industry,s shift from response ... COPAN,s Swab Rinse Kit (SRK™) ... sampling process in the wake of the new FDA ... COPAN is expanding the U.S. production of the ...
(Date:1/13/2017)... -- This morning, Stock-Callers.com draws attention to ... at yesterday,s closing bell: Clovis Oncology Inc. (NASDAQ: ... GALE ), and ACADIA Pharmaceuticals Inc. (NASDAQ: ... to develop technologies and products that combat debilitating and ... use less and cleaner energy, and provide safer, cleaner ...
Breaking Medicine Technology:
(Date:1/15/2017)... , ... January 15, 2017 , ... The Gravity Vault ... in Radnor, Pennsylvania. As construction wraps up on the 14,000+ square foot climbing gym, ... Vaults sixth location, including three in New Jersey and two in New York. With ...
(Date:1/14/2017)... ... January 13, 2017 , ... According to ... magnesium-rich Mediterranean diet may lower the risk of type 2 diabetes, Alzheimer’s, and ... many health and wellness benefits linked to a Mediterranean diet are only some ...
(Date:1/13/2017)... California (PRWEB) , ... January 13, 2017 , ... ... carbohydrates that raise blood sugar levels. Counting carbohydrates is as easy as checking ... the only nutrient that affects blood sugar levels. Despite being sugar-free, proteins can ...
(Date:1/13/2017)... ... ... KOAMTAC ®, Inc., a leading manufacturer of Bluetooth barcode scanners and mobile ... collector at the National Retail Federation’s Big Show (NRF17) held January 15-17 in New ... need for more compact and rugged devices for collecting barcode data paired with a ...
(Date:1/13/2017)... , ... January 13, 2017 , ... An inventor from ... black or brown belt in order to diversify my outfits, so he decided to ... wear. , THE T.O.O.B. enhances the appearance of a belt to allow for quick, ...
Breaking Medicine News(10 mins):